N-Propyl-2-[(5-sulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide

Catalog No. :
ACYQEF432
CAS No. :
155329-60-5
Molecular Formula :
C7H11N3OS3
Molecular Weight :
249.39

IUPAC Name:N-propyl-2-((5-thioxo-4,5-dihydro-1,3,4-thiadiazol-2-yl)thio)acetamide

N-Propyl-2-[(5-sulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$100.00Login to see priceInquiryInquiry
1g95%$336.00Login to see priceInquiryInquiry
5g95%$943.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Propyl-2-[(5-sulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide
IUPAC NameN-propyl-2-((5-thioxo-4,5-dihydro-1,3,4-thiadiazol-2-yl)thio)acetamide
MDL No.MFCD06362483
Molecular FormulaC7H11N3OS3
Molecular Weight249.39
SMILESO=C(NCCC)CSC1=NN=C(S)S1
InChI KeyXCDDHXUELYDWNZ-UHFFFAOYSA-N
Synonym2-[(5-MERCAPTO-1,3,4-THIADIAZOL-2-YL)THIO]-N-PROPYLACETAMIDE;2-[(4,5-Dihydro-5-thioxo-1,3,4-thiadiazol-2-yl)-thio]-N-propyl-acetamide;N-propyl-2-[(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)sulfanyl]acetamide;Acetamide, 2-[(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl)thio]-N-propyl-;N-Propyl-2-[(5-sulfanyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide
CAS No.155329-60-5

Synthetic Route by SureRoute

1. ACYQEF432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGTAQ598 route compound structure diagram
    ACGTAQ598556-53-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYQEF432 route product structure diagram
    ACYQEF432155329-60-5
Inquiry

2. ACYQEF432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYQEF432 route product structure diagram
    ACYQEF432155329-60-5
Inquiry

Comments (0)